Published in
Wiley Open Access, Cancer Medicine, 13(8), p. 5823-5830, 2019
DOI: 10.1002/cam4.2420
Links
Tools
Treatment duration as a surrogate endpoint to evaluate the efficacy of crizotinib in sequential therapy for patients with advanced ALK‐positive non‐small cell lung cancer: A retrospective, real‐world study
Journal article published in 2019 by
Guangjian Yang,
Di Ma 
,
Haiyan Xu,
Lu Yang ,
Junling Li,
Puyuan Xing,
Xuezhi Hao,
Yan Wang
,
Haiyan Xu,
Lu Yang ,
Junling Li,
Puyuan Xing,
Xuezhi Hao,
Yan Wang
This paper is made freely available by the publisher.
Full text: Download
Data provided by 